Navigation Links
Varian Medical Systems Schedules Investor Meeting at ASTRO in Miami Beach, FL
Date:8/23/2011

PALO ALTO, Calif., Aug. 23, 2011 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) will hold an investor event on Tuesday, October 4, at the annual meeting of the American Society for Radiation Oncology (ASTRO) in Miami Beach.  Investors and members of the financial community are invited to join senior management for a tour of the company's exhibition at ASTRO.

Varian will host a meeting with management, beginning with breakfast at 7:00 a.m. and presentations at 7:30 a.m. on Tuesday at the Loews Miami Beach Hotel, 1601 Collins Ave. Miami, in the Americana Salon Meeting Room, 2nd Floor, Main Tower.  The presentations will be followed by a tour of Varian's ASTRO booth at the Miami Beach Convention Center, Booth #1825 – from 9 a.m. to 10 a.m.  

Management presentations will focus on advances in radiotherapy and radiosurgery as well as new technologies and products within the company's Oncology Systems, and emerging businesses.  Management will include: Varian Medical Systems' CEO and President Tim Guertin; Executive Vice President and Oncology Systems President Dow Wilson; Oncology Service Vice President Kolleen Kennedy; Senior Vice President and CFO Elisha Finney; Vice President Emerging Businesses Lester Boeh; and Investor Relations Vice President Spencer Sias.

Attendees are requested to RSVP for the meeting and/or booth tour, by clicking on: http://varian.mediaroom.com/index.php?s=101, or by contacting Anne Rambo at (650) 424-5834, or by e-mail: anne.rambo@varian.com.  Please RSVP by Tuesday, September 27, 2011.  

The meeting and presentation will be webcast beginning at 7:30 a.m. pacific time.  To access the webcast, click on http://investors.
'/>"/>

SOURCE Varian Medical Systems
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
2. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
3. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
4. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
5. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
6. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
9. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
10. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
11. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Ill. , May 20, 2013 Landauer, ... in personal and environmental radiation measurement and monitoring, outsourced ... announced today that its Board of Directors declared, at ... cash dividend of $0.55 per share for the third ... on July 3, 2013, to shareholders of record on ...
(Date:5/20/2013)... May 20, 2013  Valeant Pharmaceuticals International, Inc. (NYSE: ... senior management team will make a presentation at the 34 ... 11, 2013 at 9:20 a.m. PT. The conference will be ... CA. A live webcast and audio ... Web site at www.valeant.com . Click on Investor Relations, ...
(Date:5/20/2013)... VIEW, Calif. , May 20, 2013 /PRNewswire-iReach/ ... results of the first study demonstrating detection of ... Yersinia pestis and Bacillus anthracis ... Control and Prevention,s list of potential bio-threats. This ... Science and Technology Laboratory, Salisbury ...
Breaking Medicine Technology:Landauer, Inc. Declares Regular Cash Dividend 2Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2
... April 18, 2011 Altitude Organic Corporation (Pinksheets: ... announced today that it has launched its third-party ... headquarters.  Visit the DoctorMMJ.com website ( www.DoctorMMJ.com ) ... and entirely legal medical marijuana evaluation in Arizona. ...
... 2011 Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ... Administration (FDA) has accepted for review the Company,s Biologics ... of the neovascular form of age-related macular degeneration (wet ... priority review of its BLA.  A Priority Review designation ...
Cached Medicine Technology:Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 2Altitude Organic Corporation Opens DoctorMMJ.com Physician Referral Service in Scottsdale, Arizona 3FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 2FDA Grants Priority Review for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration 3
(Date:5/21/2013)... 21, 2013 The birth control safety ... who have used the contraceptive NuvaRing. A new report ... clot injuries has increased in recent months*. , DrugRisk ... and devices with the latest safety alerts, recalls, studies ... are experiencing similar side effects and decide if they ...
(Date:5/20/2013)... 2013 USA Book News announced Monday ... Peak Performance" won the top honor in its 2013 ... over a multitude of international titles published from 2011-2013, ... acclaim from both mainstream and new age audiences looking ... and spiritually. , “The Infinity Zone” is ...
(Date:5/20/2013)... Texas (PRWEB) May 21, 2013 ... on product type into two categories - semi-automated ... market is classified into five categories, namely, hospitals, ... market is forecast till 2017. Automated external defibrillators ... of sudden cardiac arrest victims. Considering the life-saving ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 Recent ... importance of using green and sustainable inputs in ... has implemented regulations to promote the use of ... Packaging and Labelling Services industry . “Tax subsidies ... trend,” says IBISWorld industry analyst Deonta Smith. “For ...
(Date:5/20/2013)... Florida (PRWEB) May 20, 2013 In order ... supplemental health and wellness team from DrSmartphoneMD launched an article ... serious sunburns. , The series launched with the ... that members of the DrSmartphoneMD program are not one of ... team explained that more than 90% of all skin cancer ...
Breaking Medicine News(10 mins):Health News:DrugRisk Update Shows Increase in NuvaRing Blood Clot Lawsuits 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 2Health News:North America Leads Automated External Defibrillator Market (AED), Says New Research Report at ReportsnReports.com 3Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Packaging and Labelling Services in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Combat Skin Cancer In Summer Months 2
... study shows that combining high resolution and high sensitivity ... emission computed tomography (SPECT) scans, said researchers at SNM,s ... rays so that only those traveling parallel to a ... it is not yet possible to focus radiation with ...
... skin patch can safely and successfully treat basal cell ... cancers, according to researchers at the SNM,s 56th Annual ... is nontoxic and could be an excellent alternative to ... treatments is difficult. "While basal cell carcinoma is ...
... pandemic level, a new article http://www.cmaj.ca/cgi/rapidpdf/cmaj.090866 in ... oseltamivir (Tamiflu) and zanamivir (Relenza) are relatively safe drugs ... women, especially those in the third trimester, are at ... influenza virus. The study was conducted by researchers ...
... , Brand unveils four-month awareness campaign featuring Len Dawson, Ken Griffey ... with ZERO - The Project to End Prostate Cancer , ... staggering one in six men and 192,000 men expected to be ... KMB ) and the Depend brand today announced a ...
... Insight built on SAP(R) BusinessObjects(TM) software , ... /PRNewswire/ -- Tata Consultancy Services (TCS) ... business solutions and outsourcing firm, has launched Provider ... on SAP(R) BusinessObjects(TM) software for hospitals and other ...
... stories and demands for solutions to lawmakers in Washington , ... , ATLANTA, June 15 As lawmakers wrangle over health reform ... one mom is making sure people,s voices are heard. Kathie McClure, ... states to expose the gaps in our tattered healthcare system safety ...
Cached Medicine News:Health News:New skin cancer patch: Possible alternative to surgery 2Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 2Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 3Health News:Kimberly-Clark Teams Up With Sports Legends to Launch 'The Depend Campaign to End Prostate Cancer' 4Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 2Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 3Health News:Tata Consultancy Services Launches New Business Intelligence Solution for Hospitals and Healthcare Providers 4Health News:Mom on Mission for Quality, Affordable Healthcare for All Drives Purple Bus Across Nation Gathering Stories 2Health News:Mom on Mission for Quality, Affordable Healthcare for All Drives Purple Bus Across Nation Gathering Stories 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: